Pharmacological evaluation of R(+)-pulegone on cardiac excitability: Role of potassium current blockage and control of action potential waveform
dc.contributor.author | Santos-Miranda, Artur | |
dc.contributor.author | Gondim, Antonio Nei | |
dc.contributor.author | Rodrigues Menezes-Filho, Jose Evaldo | |
dc.contributor.author | Lins Vasconcelos, Carla Marina | |
dc.contributor.author | Cruz, Jader Santos | |
dc.contributor.author | Roman-Campos, Danilo [UNIFESP] | |
dc.contributor.institution | Universidade Federal de São Paulo (UNIFESP) | |
dc.contributor.institution | Universidade Federal de Minas Gerais (UFMG) | |
dc.contributor.institution | Univ Estado Bahia | |
dc.contributor.institution | Univ Fed Sergipe | |
dc.date.accessioned | 2016-01-24T14:37:49Z | |
dc.date.available | 2016-01-24T14:37:49Z | |
dc.date.issued | 2014-09-01 | |
dc.description.abstract | Introduction: R(+)-pulegone is a ketone monoterpene and it is the main constituent of essential oils in several plants. Previous studies provided some evidence that R(+)-pulegone may act on isolated cardiac myocytes. in this study, we evaluated in extended detail, the pharmacological effects of R(+)-pulegone on cardiac tissue.Methods: Using in vivo measurements of rat cardiac electrocardiogram (ECG) and patch-clamp technique in isolated myocytes we determinate the influence of R(+)-pulegone on cardiac excitability.Results: R(+)-pulegone delayed action potential repolarization (APR) in a concentration-dependent manner (EC50 = 775.7 +/- 1.48, 325.0 +/- 1.30, 469.3 +/- 1.91 mu M at 10, 50 and 90% of APR respectively). in line with prolongation of APR R(+)-pulegone, in a concentration-dependent manner, blocked distinct potassium current components (transient outward potassium current (I-to), rapid delayed rectifier potassium current (I-kr), inactivating steady state potassium current (I-ss) and inward rectifier potassium current (I-K1)) (EC50 = 1441 +/- 1.04; 605.0 +/- 1.22, 818.7 +/- 1.22; 1753 +/- 1.09 mu M for I-to, I-Kr, I-ss and I-K1, respectively). the inhibition occurred in a fast and reversible way, without changing the steady-state activation curve, but instead shifting to the left the steady-state inactivation curve (V-1/2 from -56.92 +/- 0.35 to 67.52 +/- 0.19 mV). in vivo infusion of 100 mg/kg R(+)-pulegone prolonged the QTc (similar to 40%) and PR (similar to 62%) interval along with reducing the heart rate by similar to 26%.Conclusion: Taken together, R(+)-pulegone prolongs the APR by inhibiting several cardiomyocyte current components in a concentration-dependent manner. This occurs through a direct block by R(+)pulegone of the channel pore, followed by a left shift on the steady state inactivation curve. Finally, R(+)-pulegone induced changes in some aspects of the ECG profile, which are in agreement with its effects on potassium channels of isolated cardiomyocytes. (C) 2014 Elsevier GmbH. All rights reserved. | en |
dc.description.affiliation | Universidade Federal de São Paulo, Escola Paulista Med, Dept Biofis, São Paulo, Brazil | |
dc.description.affiliation | Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil | |
dc.description.affiliation | Univ Estado Bahia, Dept Educ, Lab Lab Biofis & Farmacol Coracao, Guanambi, Bahia, Brazil | |
dc.description.affiliation | Univ Fed Sergipe, Dept Fisiol, Lab Biofis Coracao, Aracaju, Sergipe, Brazil | |
dc.description.affiliationUnifesp | Universidade Federal de São Paulo, Escola Paulista Med, Dept Biofis, São Paulo, Brazil | |
dc.description.source | Web of Science | |
dc.description.sponsorship | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) | |
dc.description.sponsorship | Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) | |
dc.description.sponsorship | FAPITEC/SE | |
dc.format.extent | 1146-1153 | |
dc.identifier | http://dx.doi.org/10.1016/j.phymed.2014.05.007 | |
dc.identifier.citation | Phytomedicine. Jena: Elsevier Gmbh, Urban & Fischer Verlag, v. 21, n. 10, p. 1146-1153, 2014. | |
dc.identifier.doi | 10.1016/j.phymed.2014.05.007 | |
dc.identifier.issn | 0944-7113 | |
dc.identifier.uri | http://repositorio.unifesp.br/handle/11600/38175 | |
dc.identifier.wos | WOS:000340336700003 | |
dc.language.iso | eng | |
dc.publisher | Elsevier B.V. | |
dc.relation.ispartof | Phytomedicine | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.license | http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy | |
dc.subject | Pulegone | en |
dc.subject | Myocyte | en |
dc.subject | Heart | en |
dc.subject | Electrocardiogram | en |
dc.subject | Action potential | en |
dc.subject | Potassium current | en |
dc.title | Pharmacological evaluation of R(+)-pulegone on cardiac excitability: Role of potassium current blockage and control of action potential waveform | en |
dc.type | info:eu-repo/semantics/article |